NANOVESICLES WITH 1% Titrate Extracts of Centella Asiatica (TECA)
An innovation designed for the deepest dermal routine, featuring 100–300 nm lipid bilayer shell technology that is highly compatible with the skin’s stratum corneum. It is engineered for controlled and slow release into the dermal layer, while enhancing bioavailability and bio-efficacy, and offering high stability against light, heat, and high-shear processing.
TECA active compounds help regulate inflammatory pathways. Asiatic Acid provides antioxidant and antibacterial activity, while the synergistic action of Asiaticoside and Madecassic Acid helps reduce inflammatory responses and support acne lesion recovery.
Supports the skin repair process by promoting cell migration, fibroblast activity, and extracellular matrix formation. This accelerates tissue remodeling and improves skin recovery after inflammatory damage.
Stimulate collagen synthesis and support dermal reconstruction, resulting in improved skin strength, elasticity, and overall skin quality.
Stimulates fibroblast activity and collagen synthesis while supporting dermal reconstruction.
Helps regulate inflammatory responses and supports recovery of irritated skin.
Provides antioxidant and antimicrobial activity while helping reduce oxidative stress and acne-related inflammation.
AVERAGE NANOPARTICLE SIZE
ENTRAPMENT EFFICACY
Zeta-Potential
Optimized Penetration Dimension with 100 – 300 nm , each niosome is small enough to navigate the intercellular lipid pathway of the stratum corneum while remaining large enough to avoid systemic absorption, maintaining a topical-localized action. It’s enhanced deposition in the viable epidermis and upper dermis and superior bioavailability of both hydrophilic and lipophilic actives through dual-phase distribution.
INCI : ASIATICOSIDE, MADECASSIC ACID, ASIATIC ACID, and others (Please contact us to get more information)
RECOMMEND DOSAGE : 3-15%
CONCERN :
– Incompatible with strong acids, bases, oxidizers and reducers.
– Recommended pH range between 5.0 and 8.0 to avoid conformational changes.
TDDS offered the controlled release diffusion with deepest penetration to deliver encapsulated active ingredients through stratum corneum barrier functioned to target cells as Melanocyte, Keratinocyte, Basal layer, Fibroblast and Mast cells.
